- ICH GCP
- US-Register für klinische Studien
- Klinische Studie NCT02931851
Family Information Management in the Intensive Care Unit (ICU-Families)
Family Information Management in the Intensive Care Unit: A Randomized Controlled Trial
Relatives in intensive care units (ICU) are important partners in decision-making in the treatment of critically ill patients and provide a significant resource in the care and recovery of patients. Therefore, a professional, educational intervention targeting these caregivers may have fundamental benefits with little risk. As in other fields, information is searched in the internet, but this unselected information is often overwhelming and of little use in this context.
Symptoms of anxiety, stress and depression are common in affected relatives. The majority of family members report some level of anxiety, depression and stress, sometimes even resulting in post-traumatic stress disorder (PTSD). Importantly, an association between lack of information and post-traumatic stress disorder PTSD has been reported. The large number of potentially affected families poses a particular challenge to healthcare and may cause substantial secondary costs to national economy.
Studienübersicht
Status
Bedingungen
Intervention / Behandlung
Detaillierte Beschreibung
Design:
- Phase: Empirical study (quantitative) of information needs - semi-structured interviews with family members, physicians and caregivers
- Phase: Development of user friendly homepage with University of Applied Sciences Joanneum and validation of the homepage with medical professionals and laypersons
- Phase: Randomized Controlled Trial (non-blinded) with "placebo home page" (N=110)
Background:
Relatives in intensive care units (ICU) are important partners in decision-making in the treatment of critically ill patients and provide a significant resource in the care and recovery of patients. Therefore, a professional, educational intervention targeting these caregivers may have fundamental benefits with little to no risk. As in other fields, information is searched in the internet, but this unselected information is often overwhelming and of little use in this context.
In Austria there are 2784 systemized intensive care beds with an average occupation of 3,6 days, representing 100 new admissions per year/ICU bed. This may translate to 500.000 affected family members per year.
The role of family members in the treatment process of ICU patients is a not very well studied subject, especially in German-speaking countries. In contrast, in the Anglo-American world, family members play a key role in the medical, financial and legal aspects of the treatment process and have a decisive role in the successful treatment during and after critical illness.
Symptoms of anxiety, stress and depression are common in affected relatives . The majority of family members report some level of anxiety, depression and stress, sometimes even resulting in post-traumatic stress disorder (PTSD). Importantly, an association between lack of information and post-traumatic stress disorder PTSD has been reported. The large number of potentially affected families poses a particular challenge to healthcare and may cause substantial secondary costs to national economy.
The participation of relatives in the decision making process of ICU patients is negatively affected by the uncertainty concerning the treatment path, medical procedures and consequences for the families' life after ICU discharge. This likely leads to unnecessary hospital readmissions, complicates rehabilitation of patients and requires adapted management strategies for relatives. Therefore, it is important to provide sufficient information to families in high quality.
The relationship management with relatives places significant demands on ICU staff and conflicts between physicians and relatives are common. So far, only a few randomized intervention studies have been performed in this setting, but with promising results.
The internet has revolutionized our world including the access to medical information. In one study, almost 50% of ICU patients' family members used the internet for information purposes within the first days of ICU treatment. This makes a web-based intervention in this setting very promising. To our knowledge however, no RCT has yet evaluated the usefulness of a web-based intervention on ICU patients' family members' quality of life.
The following question should therefore be answered by our study:
- Does targeted information and communication using new media (INTERVENTION) have a beneficial influence on subjective and objective endpoints of patients and their families?
- Could this help in averting the negative effects of anxiety, stress, and depression? Are new media accepted in clinical routine?
- Does the project support the affected family members in their health literacy?
Studientyp
Einschreibung (Tatsächlich)
Phase
- Unzutreffend
Kontakte und Standorte
Studienorte
-
-
-
Bern, Schweiz
- University of Berne - Inselspital
-
-
-
-
-
Graz, Österreich, 8036
- Medical University of Graz
-
Vienna, Österreich
- Medical University of Vienna
-
-
Teilnahmekriterien
Zulassungskriterien
Studienberechtigtes Alter
Akzeptiert gesunde Freiwillige
Studienberechtigte Geschlechter
Beschreibung
Inclusion Criteria:
- anticipated further ICU stay ≥3 days (index patient)
Exclusion Criteria:
- lack of Basic Information Technology (IT) user knowledge or German language skills
- DNR (Do not resuscitate) orders (index patient)
Studienplan
Wie ist die Studie aufgebaut?
Designdetails
- Hauptzweck: Verhütung
- Zuteilung: Zufällig
- Interventionsmodell: Parallele Zuordnung
- Maskierung: Vervierfachen
Waffen und Interventionen
Teilnehmergruppe / Arm |
Intervention / Behandlung |
---|---|
Placebo-Komparator: Placebo
Standard Information
|
Standard Information provided online
|
Aktiver Komparator: Intervention
Professionally developed website for relatives of ICU patients
|
Professionally developed website for relatives of ICU patients
|
Was misst die Studie?
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
---|---|---|
Subjective distress
Zeitfenster: 30 Days
|
Impact of Event Score (IES: symptoms of post traumatic stress disorder)
|
30 Days
|
Sekundäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
---|---|---|
Levels of anxiety and depression
Zeitfenster: 30 days
|
Measured by Hospital Anxiety and Depression Score (HADS)
|
30 days
|
Subjective usefulness of the website for relatives
Zeitfenster: 30 days
|
Subjective Evaluation
|
30 days
|
Length of stay
Zeitfenster: 90 days
|
ICU and Hospital length of stay of the index patients
|
90 days
|
Readmissions
Zeitfenster: 90 days
|
number of readmissions of the index patients
|
90 days
|
Mortality
Zeitfenster: 90 days
|
mortality of the index patients
|
90 days
|
User-statistics
Zeitfenster: 30 days
|
user statistics for the website
|
30 days
|
Mitarbeiter und Ermittler
Sponsor
Ermittler
- Hauptermittler: Karin Amrein, MD, MSc, Medical University of Graz
Publikationen und hilfreiche Links
Allgemeine Veröffentlichungen
- Lautrette A, Darmon M, Megarbane B, Joly LM, Chevret S, Adrie C, Barnoud D, Bleichner G, Bruel C, Choukroun G, Curtis JR, Fieux F, Galliot R, Garrouste-Orgeas M, Georges H, Goldgran-Toledano D, Jourdain M, Loubert G, Reignier J, Saidi F, Souweine B, Vincent F, Barnes NK, Pochard F, Schlemmer B, Azoulay E. A communication strategy and brochure for relatives of patients dying in the ICU. N Engl J Med. 2007 Feb 1;356(5):469-78. doi: 10.1056/NEJMoa063446. Erratum In: N Engl J Med. 2007 Jul 12;357(2):203.
- Azoulay E, Kentish-Barnes N, Nelson JE. Communication With Family Caregivers in the Intensive Care Unit: Answers and Questions. JAMA. 2016 May 17;315(19):2075-7. doi: 10.1001/jama.2016.5637. No abstract available.
- Peigne V, Chaize M, Falissard B, Kentish-Barnes N, Rusinova K, Megarbane B, Bele N, Cariou A, Fieux F, Garrouste-Orgeas M, Georges H, Jourdain M, Kouatchet A, Lautrette A, Legriel S, Regnier B, Renault A, Thirion M, Timsit JF, Toledano D, Chevret S, Pochard F, Schlemmer B, Azoulay E. Important questions asked by family members of intensive care unit patients. Crit Care Med. 2011 Jun;39(6):1365-71. doi: 10.1097/CCM.0b013e3182120b68.
Studienaufzeichnungsdaten
Haupttermine studieren
Studienbeginn (Tatsächlich)
Primärer Abschluss (Tatsächlich)
Studienabschluss (Tatsächlich)
Studienanmeldedaten
Zuerst eingereicht
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst gepostet (Schätzen)
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Tatsächlich)
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Zuletzt verifiziert
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Andere Studien-ID-Nummern
- ICU-Families 1.0
Plan für individuelle Teilnehmerdaten (IPD)
Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?
Arzneimittel- und Geräteinformationen, Studienunterlagen
Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt
Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .
Klinische Studien zur Extended Family
-
Kaleido BiosciencesBeendetVancomycin-resistente Enterococcus-, Extended-Spectrum-Beta-Lactamase-produzierende Enterobacteriaceae- oder Carbapenem-resistente Enterobacteriaceae-Kolonisierte PersonenVereinigte Staaten
-
Boston Children's HospitalAgency for Healthcare Research and Quality (AHRQ); Pediatric Research in Inpatient...RekrutierungQualitätsverbesserung | Patientensicherheit | Von der Familie gemeldete Fehler und unerwünschte Ereignisse | Gesundheitliche disparitäten | Family Safety Reporting | Freiwillige Meldung von VorfällenVereinigte Staaten
-
University of BordeauxUnbekanntAssoziation von Darmmikrobiota mit ESBL-E-Kolonisierung und nachfolgender ESBL-E-Infektion (Microbe)Kritische Krankheit | Mikrobielle Besiedlung | Extended Spectrum Beta-Lactamase produzierende BakterieninfektionFrankreich
-
University Hospital, Basel, SwitzerlandGebert Rüf-StiftungAktiv, nicht rekrutierendExtended Spectrum Beta-Lactamasen (ESBL) E. ColiSchweiz
-
Norwegian Institute of Public HealthUniversity of BergenRekrutierungErmüdung | Schlaflosigkeit | Gesundheit, Subjektiv | Psychische Belastung | Schichtarbeits-Schlafstörung | Krankenstand | Arbeitsunfall | Umsatzabsicht | Work-Family SpilloverNorwegen
-
Eva Morava-KoziczNoch keine RekrutierungSLC35A2-CDG – Solute Carrier Family 35 Mitglied A2 Angeborene Störung der GlykosylierungVereinigte Staaten
-
The Methodist Hospital Research InstituteM.D. Anderson Cancer Center; National Institute of Allergy and Infectious Diseases... und andere MitarbeiterRekrutierungAntibiotikaresistente Infektion | Clostridium difficile | Resistenz gegen antimikrobielle Medikamente | Carbapenem-resistente Enterobacteriaceae-Infektion | Vancomycin-resistente Enterokokken-Infektion | Vancomycin-resistente Enterokokken-Infektion | Carbapenem-resistente bakterielle Infektion | Extended Spectrum Beta-Lactamase produzierende BakterieninfektionVereinigte Staaten
-
Hospital Ruber InternacionalRekrutierungRefraktäre Epilepsie | SLC35A2-CDG – Solute Carrier Family 35 Mitglied A2 Angeborene Störung der GlykosylierungSpanien
Klinische Studien zur Placebo
-
SamA Pharmaceutical Co., LtdUnbekanntAkute Bronchitis | Akute Infektion der oberen AtemwegeKorea, Republik von
-
National Institute on Drug Abuse (NIDA)AbgeschlossenCannabiskonsumVereinigte Staaten
-
AstraZenecaParexel; Spandauer Damm 130; 14050; Berlin, GermanyAbgeschlossenMännliche Probanden mit Typ-II-Diabetes (T2DM)Deutschland
-
Instituto de Investigación Hospital Universitario...Creaciones Aromáticas Industriales, S.A. (CARINSA)Abgeschlossen
-
Texas A&M UniversityNutraboltAbgeschlossenGlucose and Insulin Response
-
Soroka University Medical CenterAbgeschlossen
-
Regado Biosciences, Inc.AbgeschlossenGesunder FreiwilligerVereinigte Staaten
-
ItalfarmacoAbgeschlossenBecker-MuskeldystrophieNiederlande, Italien
-
Heptares Therapeutics LimitedAbgeschlossenPharmakokinetik | SicherheitsproblemeVereinigtes Königreich